---
title: "Clear Street Reaffirms Their Buy Rating on Comstock Resources (CRK)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294404449.md"
description: "Clear Street analyst Tim Moore reaffirmed a Buy rating on Comstock Resources (CRK) with a $23 price target. This contrasts with the broader market consensus, which rates CRK as a Hold with an average target of $15.56. Moore, who covers Industrials stocks including MasTec and Bloom Energy, has a historical success rate of 35%."
datetime: "2026-07-30T18:55:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294404449.md)
  - [en](https://longbridge.com/en/news/294404449.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294404449.md)
generator: "portal-rs"
---

# Clear Street Reaffirms Their Buy Rating on Comstock Resources (CRK)

In a report released today, Tim Moore CFA from Clear Street maintained a Buy rating on Comstock Resources, with a price target of $23.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Moore CFA is an analyst with an average return of -13.2% and a 35.00% success rate. Moore CFA covers the Industrials sector, focusing on stocks such as MasTec, MYR Group, and Bloom Energy.

Currently, the analyst consensus on Comstock Resources is a Hold with an average price target of $15.56.

### Related Stocks

- [CRK.US](https://longbridge.com/en/quote/CRK.US.md)
- [MTZ.US](https://longbridge.com/en/quote/MTZ.US.md)
- [MYRG.US](https://longbridge.com/en/quote/MYRG.US.md)
- [BE.US](https://longbridge.com/en/quote/BE.US.md)

## Related News & Research

- [UBS Reaffirms Their Sell Rating on Comstock Resources (CRK)](https://longbridge.com/en/news/289913853.md)
- [Roth MKM Keeps Their Sell Rating on Comstock Resources (CRK)](https://longbridge.com/en/news/289831624.md)
- [Analyst Reiterates Buy on Cogent Biosciences, Maintains $55 Price Target Amid Late-Stage Pipeline and Strong Cash Position](https://longbridge.com/en/news/296384188.md)
- [Lowe’s Earns Buy Rating as Strong Earnings and Cash Generation Offset Lower-End Guidance](https://longbridge.com/en/news/296383656.md)
- [Telsey Advisory Sticks to Their Buy Rating for Abercrombie Fitch (ANF)](https://longbridge.com/en/news/296366488.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**